John P. Veluchamy

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

John P. Veluchamy, Jan Spanholtz, Marleen Tordoir et al. · PLoS ONE · 2016 · 85 citations · Full text

Life Sciences, Immunology, Oncology +17

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

Renée C.G. de Bruin, John P. Veluchamy, Sinéad M. Lougheed et al. · OncoImmunology · 2017 · 84 citations · Full text

Life Sciences, Immunology, Oncology +17

In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer

John P. Veluchamy, Silvia Lopez‐Lastra, Jan Spanholtz et al. · Frontiers in Immunology · 2017 · 49 citations · Full text

Medicine, Immunology, Oncology +16

Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells

Francesco Grimaldi, Victoria Potter, Pilar Perez-Abellan et al. · Biology of Blood and Marrow Transplantation · 2016 · 36 citations · Full text

Medicine, Hematology, Immunology +17

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status

John P. Veluchamy, A. Marijne Heeren, Jan Spanholtz et al. · Cancer Immunology Immunotherapy · 2016 · 35 citations · Full text

Medicine, Immunology, Oncology +9